| Dose Escalation Study of MLN0128 in Relapsed or Refractory Multiple Myeloma or Waldenstrom Macroglobulinemia (NCT01118689) | Millennium Pharmaceuticals, Inc. | 2010-11-01 |
| MK-4827 in Combination With Pegylated Liposomal Doxorubicin in Participants With Advanced Solid Tumors and Ovarian Cancer (MK-4827-011) (NCT01227941) | Tesaro, Inc. | 2010-11-01 |
| Dose-Finding Study of PDC31 in Patients With Primary Dysmenorrhea (NCT01250587) | PDC Biotech GmbH | 2010-11-01 |
| A Study To Look At Safety And Blood Concentrations After Multiple Doses Of PF-03382792 In Healthy Elderly Individuals (NCT01089738) | Pfizer | 2010-11-01 |
| Treatment of Corneal Neovascularization With Topical Pazopanib (NCT01257750) | Reza Dana, MD | 2010-11-01 |
| Safety Study for Intravenous (IV) AC480 (AC480IV) to Treat Advanced Solid Tumors (NCT01245543) | Daiichi Sankyo | 2010-11-01 |
| Single Dose Bioequivalence Study Comparing Nifedipine/Candesartan FDC (Fixed Dose Combination) With Loose Combination of Nifedipine GITS (Gastro-intestinal Therapeutic System) Plus Candesartan and Single Components Under Fasting Conditions (NCT01227603) | Bayer | 2010-11-01 |
| A Study of LY2608204 in Patients With Type 2 Diabetes (NCT01247363) | Eli Lilly and Company | 2010-11-01 |
| Pharmacokinetics and Food Effect of Single Oral Dose of E7050 in Healthy Volunteers (NCT02533102) | Eisai Limited | 2010-11-01 |
| A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer (NCT01237678) | ImmunoGen, Inc. | 2010-11-01 |
| Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Subjects (NCT01252641) | Sangamo Therapeutics | 2010-11-01 |
| Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease (NCT01245179) | Abdullah Kutlar | 2010-11-01 |
| Bimanual Training in Children With Hemiplegia With Lower Limb and Postural Stimulation (HABIT & Leg) (NCT01700777) | University Hospital of Mont-Godinne | 2010-11-01 |
| Curcumin Biomarkers (NCT01333917) | University of North Carolina, Chapel Hill | 2010-11-01 |
| Safety and Efficacy of Radio-immunotherapy (RIT) for Patients With Relapse or Refractory Acute Lymphoblastic Leukaemia (ALL) B CD22+ (NCT01354457) | Nantes University Hospital | 2010-11-01 |
| Probiotics as a Novel Approach to Modulate Gut Hormone Secretion and Risk Factors of Type 2 Diabetes and Complications (NCT01250106) | German Diabetes Center | 2010-11-01 |
| Feasibility Study to Assess the Safety and Functionality of the GluSense Continuous Glucose Monitor in Diabetic Patients (NCT01198678) | GluSense Ltd | 2010-11-01 |
| Non-invasive Neurally Adjusted Ventilatory Assist (NCT01280383) | Insel Gruppe AG, University Hospital Bern | 2010-11-01 |
| A Study of the Effect of RO4917838 on Biomarker Measures of Cognitive Dysfunction in Participants With Schizophrenia and Schizoaffective Disorder (NCT01116830) | Hoffmann-La Roche | 2010-11-01 |
| An Open-Label, Dose-Escalation Study of AZD2461 (NCT01247168) | AstraZeneca | 2010-11-01 |
| E2022 Patch Formulation Single Dose Phase I Study (NCT01253434) | Eisai Co., Ltd. | 2010-11-01 |
| A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase. (NCT01219543) | AstraZeneca | 2010-11-01 |
| Pharmacokinetic (PK)/Pharmacodynamic (PD), Study of Single-dose Subcutaneous CDP6038 in Healthy Japanese Male Subjects (NCT01262794) | UCB Pharma | 2010-11-01 |
| Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 Multiple Doses in Healthy Japanese Volunteers (NCT01233830) | AstraZeneca | 2010-11-01 |
| PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors (NCT01158300) | Pediatric Brain Tumor Consortium | 2010-11-01 |
| A Dose-Ranging Study of JNJ-40411813 in Healthy Male Volunteers (NCT01358006) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-11-01 |
| Refractory Out-Of-Hospital Cardiac Arrest Treated With Mechanical CPR, Hypothermia, ECMO and Early Reperfusion (NCT01186614) | Bayside Health | 2010-11-01 |
| Pharmacokinetics of Dabigatran Etexilate (Pradaxa®) During Haemodialysis (NCT01241539) | Boehringer Ingelheim | 2010-11-01 |
| An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of Two Controlled Release Pregabalin Tablets As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule In Healthy Volunteers (NCT01220219) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-11-01 |
| Effect of AT7519M Alone and AT7519M Plus Bortezomib in Patients With Previously Treated Multiple Myeloma (NCT01183949) | Astex Pharmaceuticals, Inc. | 2010-11-01 |
| Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs (NCT01263353) | Novartis Pharmaceuticals | 2010-11-01 |
| A Study to Assess the Transfer of Fospropofol and Its Active Metabolite, Propofol, to Breast Milk Following Administration of LUSEDRA to Lactating Women Undergoing a Needed Procedure (NCT01309984) | Eisai Inc. | 2010-11-01 |
| CKD-828(80/2.5mg) Pharmacokinetic Study (NCT01246193) | Chong Kun Dang Pharmaceutical | 2010-11-01 |
| Study of Postoperative Concurrent Chemo-radiation With Capecitabine in Elderly Rectal Cancer Patients (NCT01268943) | Chinese Academy of Medical Sciences | 2010-11-01 |
| A Study In Healthy Volunteers To Assess The Safety, Tolerability, And Relative Oral Bioavailability Of Three Formulations Of PH-797804 (NCT01226693) | Pfizer | 2010-11-01 |
| A Study of LY3009104(Baricitinib) for Healthy Subjects (NCT01247350) | Eli Lilly and Company | 2010-11-01 |
| A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer (NCT01291407) | Chinese Academy of Medical Sciences | 2010-11-01 |
| Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel (NCT01234038) | Ionis Pharmaceuticals, Inc. | 2010-11-01 |
| Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive Disorder (NCT01354314) | Johns Hopkins University | 2010-11-01 |
| A Study of Pharmacokinetic Drug Interaction Study of the Hedgehog Pathway Inhibitor GDC-0449 in Combination With Rosiglitazone or Combined Oral Contraceptive in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists (NCT01209143) | Genentech, Inc. | 2010-11-01 |
| Japanese Single and Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic (PK) & Pharmacodynamic (PD) Study of AZD7687 (NCT01217905) | AstraZeneca | 2010-11-01 |
| To Evaluate the Effect of AZD3199 on the Electrical Activity in the Heart (NCT01222442) | AstraZeneca | 2010-11-01 |
| A Study to Evaluate the Long-Term Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome) (NCT01242111) | BioMarin Pharmaceutical | 2010-11-01 |
| To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers (NCT01253655) | Pfizer | 2010-11-01 |
| The Influence of GINkGo Biloba on the Pharmacokinetics of the UGT Substrate raltEgraviR (GINGER) (NCT01246804) | Radboud University Medical Center | 2010-11-01 |
| Safety and Tolerability Study of REGN846 (SAR302352) in Healthy Volunteers (NCT01209793) | Regeneron Pharmaceuticals | 2010-11-01 |
| A Study In Healthy Subjects Of Single Doses of PF-05230901 Injected Under The Skin (NCT01262690) | Pfizer | 2010-11-01 |
| An Interaction Study to Evaluate the Effect of Esomeprazole/Acetylsalicylic Acid on the Metabolism and Effect of Clopidogrel (NCT01210339) | AstraZeneca | 2010-11-01 |
| Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer (NCT01253681) | Amgen | 2010-11-01 |
| Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively (PEARL2) (NCT01884597) | Hawaii Pacific Health | 2010-11-01 |
| Effect of Dexlansoprazole on Bone Homeostasis (NCT01216293) | Takeda | 2010-11-01 |
| Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies (NCT01242072) | Alaunos Therapeutics | 2010-11-01 |
| Safety Study of BMS-903452 in Healthy Subjects (Panel 1-7) & Relative Bioavailability of the Crystalline and Amorphous Forms of BMS-903452 [Panels 4, 6, 11 & 12(Part A)], and Subjects With Type 2 Diabetes Mellitus (Part B) (NCT01240980) | Bristol-Myers Squibb | 2010-11-01 |
| Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma (NCT00803374) | Bristol-Myers Squibb | 2010-11-01 |
| Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448 (NCT01132404) | Millennium Pharmaceuticals, Inc. | 2010-11-01 |
| Effect of Traditional Chinese Medicine (TCM) on Embryo Implantation in In-vitro Fertilization (IVF) Patients (NCT01296009) | Wuhan University | 2010-11-01 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RDX5791 in Healthy Volunteers (NCT02819687) | Ardelyx | 2010-11-01 |
| Trial for Quantity-Effect Relationship of Acupuncture With Two-ways Regulation to Treat Functional Enteropathy (NCT01274793) | Huazhong University of Science and Technology | 2010-11-01 |
| A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients With Relapsed or Refractory t(4;14)-Positive Multiple Myeloma (NCT01122875) | Genentech, Inc. | 2010-11-01 |
| Transcranial Laser Therapy in the Rehabilitation of Hemiplegic Patients From Ischemic Stroke (NCT01308216) | Hospital Universitario Ramon y Cajal | 2010-11-01 |
| Single-dose, Study of RBP-6000 in Opioid Dependent Individuals (NCT02765867) | Indivior Inc. | 2010-11-01 |
| Formulation Comparison in Normal Volunteers (NCT01250197) | Aerie Pharmaceuticals | 2010-11-01 |
| PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volunteers (NCT01205321) | Lantheus Biosciences Ltd. | 2010-11-01 |
| Safety and Efficacy Study of IGF-1 in Duchenne Muscular Dystrophy (NCT01207908) | Children's Hospital Medical Center, Cincinnati | 2010-11-01 |
| TMC435-TiDP16-C114 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents TMC278 and Tenofovir (NCT01205139) | Tibotec Pharmaceuticals, Ireland | 2010-11-01 |
| A Bioequivalence Study of SPARC_147709 in Patients With Multiple Myeloma (NCT00863174) | Sun Pharma Advanced Research Company Limited | 2010-11-01 |
| A Study to Assess Intraocular Pressure and Ocular Safety of the Beta-3 Agonist Mirabegron in Research Subjects (NCT01284309) | Astellas Pharma Inc | 2010-11-01 |
| Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration (NCT01255462) | Novartis Pharmaceuticals | 2010-11-01 |
| A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal Women (NCT01250145) | Eli Lilly and Company | 2010-11-01 |
| Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects (NCT01220232) | Pfizer | 2010-11-01 |
| A Study Conducted Over 3 Periods to Look at the Drug in the Body (NCT01225939) | AstraZeneca | 2010-11-01 |
| A Study Comparing the Drug Exposure in Humans After Administration of a 50 mg Tablet of Sertraline Hydrochloride as Compared to a 50 mg Capsule of Sertraline Hydrochloride Under Fasted (Nonfed) Conditions (NCT01235195) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-11-01 |
| Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP (NCT02983097) | Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH | 2010-11-01 |
| A Study of 28431754 (Canagliflozin) on Gastrointestinal Glucose Absorption and Metabolism in Healthy Volunteers (NCT01173549) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-11-01 |
| Satiety Study of a Carbohydrate Meal to a Highly Viscous Gel Meal (NCT01875627) | Unity Health Toronto | 2010-11-01 |
| Randomized Study to Assess the Effect of ThRombus Aspiration on Flow Area in STEMI Patients (NCT01271361) | Terumo Europe N.V. | 2010-11-01 |
| Operative Versus Non Operative Treatment of Proximal Humerus (Shoulder Joint) Fractures (NCT00818987) | University of British Columbia | 2010-11-01 |
| Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer (NCT01245205) | National Cancer Institute (NCI) | 2010-11-01 |
| Feasibility Study Of Adding Bortezomib to R-ICE Chemotherapy To Treat Relapsed/ Refractory Diffuse Large B-Cell Lymphoma (NCT01226849) | Singapore General Hospital | 2010-11-01 |
| Novel MRI Techniques in the Evaluation of Pulmonary Vascular Disease (NCT02026531) | Sheffield Teaching Hospitals NHS Foundation Trust | 2010-11-01 |
| Study of IRNEA (Irinotecan, Etoposide, Cytarabine) for Refractory or Relapsed Acute Leukemia in Children and Adolescents (NCT01239485) | Seoul National University Hospital | 2010-11-01 |
| Safety of Hib Vaccine (Bio Farma) (NCT01977170) | PT Bio Farma | 2010-11-01 |
| Cardiac Hemodynamics in Overlap Syndrome (COPD With Obstructive Sleep Apnea) (NCT01261377) | Brigham and Women's Hospital | 2010-11-01 |
| Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care Residents (NCT01262300) | University of Colorado, Denver | 2010-11-01 |
| Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients (NCT01278810) | Chinese Academy of Medical Sciences | 2010-11-01 |
| Safety and Immunogenicity Of A Recombinant H5N1 Vaccine In Adults (NCT01250795) | Fraunhofer, Center for Molecular Biotechnology | 2010-11-01 |
| RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast Cancer (NCT01208441) | National Cancer Institute (NCI) | 2010-11-01 |
| Accuracy, Reliability and Safety of GlucoMen®Day, a New Generation Microdialysis Continuous Glucose Monitor (NCT01407315) | Medical University of Graz | 2010-11-01 |
| A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors (NCT01306630) | AVEO Pharmaceuticals, Inc. | 2010-11-01 |
| Relative Bioavailability of Empagliflozin (BI 10773) (Final Formulation) Compared to Empagliflozin (BI 10773 XX) (Trial Formulation 2) in Healthy Male and Female Volunteers (NCT01242176) | Boehringer Ingelheim | 2010-11-01 |
| Single Dose Two-periods Crossover Bioequivalence Study of Darifenacin Tablets in Healthy Volunteers. (NCT01227811) | Center for Clinical Pharmacology Research Bdbeq S.A. | 2010-11-01 |
| A Study to Assess the Effects of Single Ascending Doses (SAD) of ASP8477, the Effect That Food Has on the Drug, and the Interaction Between ASP8477 and Omeprazole in Healthy Postmenopausal Females and Healthy Young Vasectomized Males (NCT02220777) | Astellas Pharma Europe B.V. | 2010-11-01 |
| Study to Assess Safety and Tolerability of AZD4547 in Japanese Patient (NCT01213160) | AstraZeneca | 2010-11-01 |
| Study of OTSGC-A24 Vaccine in Advanced Gastric Cancer (NCT01227772) | National University Hospital, Singapore | 2010-11-01 |
| Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme (NCT01205334) | Baylor College of Medicine | 2010-11-01 |
| Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled, Study to Assess Safety, Tolerability, PK and PD Response of PB1023 Injection Following Single and Multiple SQ Doses in Adults With Type 2 Diabetes Mellitus (NCT01236404) | PhaseBio Pharmaceuticals Inc. | 2010-11-01 |
| A Study of Fostamatinib in Subjects With Impaired Kidney Function (NCT01245790) | AstraZeneca | 2010-11-01 |
| A Study to Investigate the Impact of Dose and Dosing Frequency of AZD8848 on the Response on Biomarkers (NCT01203124) | AstraZeneca | 2010-11-01 |
| Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects (NCT01145859) | Bayer | 2010-11-01 |
| Safety Study of MG1102 in Patients With Solid Tumors (NCT01809912) | Green Cross Corporation | 2010-11-01 |